At the end of the four-day treatment period, all mice were euthanized with an overdose of ketamine and xylazine
Retatrutide is an investigational triple-agonist (GLP-1, GIP, and glucagon) with a half-life of roughly 6 days (Coskun et al., Cell Metabolism, 2022)
Health Secretary Robert F Kennedy Jr, speaking at the White House, said the deals were products of months of negotiations with Eli Lilly and Novo Nordisk
Compound-Level Safety Notes BPC-157 has not produced a lethal dose in animal toxicity studies, and reported adverse events in human anecdotal use are mild and infrequent
Is there an oral alternative as effective as the weekly injections
Temporary dryness or peeling